指南与共识头颈CTMRUSPET

唾液腺癌的诊断影像学:REFCOR 采用正式共识方法制定的建议

Diagnostic imaging of salivary gland cancers: REFCOR recommendations by the formal consensus method.
指南 / 共识 · Eur Ann Otorhinolaryngol Head Neck Dis · 2023-11-29

法国罕见头颈肿瘤网络(REFCOR)组建指导组,通过叙述性文献综述和正式共识方法制定唾液腺肿瘤影像学建议。建议:唾液腺肿胀可触及3周时行超声检查;唾液腺肿瘤推荐MRI(含弥散加权和动态对比增强);组织学证实恶性或高度可疑病变时推荐颈部和胸部CT评估肿瘤、淋巴结和转移;FDG-PET目前不推荐用于常规临床实践中的初始诊断、范围评估、治疗反应评价、复发分期或随访。

要点

  • 唾液腺肿胀可触及3周时,推荐超声检查确认肿瘤性病变并排除鉴别诊断。
  • 唾液腺肿瘤推荐MRI,采用弥散加权和动态对比增强技术。
  • 组织学证实恶性或高度可疑病变时,推荐颈部和胸部CT评估肿瘤、淋巴结和转移。

核心结论

  • 唾液腺肿瘤的评估以MRI为基础,范围评估以颈部和胸部CT为基础。

研究设计与样本

  • REFCOR组建指导组,对Medline发表的文献进行叙述性综述并提出建议,再由评级组按正式共识方法评估对建议的依从性。

诊断标准与关键数值

  • 唾液腺肿胀可触及3周时,推荐超声检查确认肿瘤性病变并排除鉴别诊断。
  • 唾液腺肿瘤推荐MRI,采用弥散加权和动态对比增强技术。
  • 组织学证实恶性或高度可疑病变时,推荐颈部和胸部CT评估肿瘤、淋巴结和转移。
  • FDG-PET目前不推荐用于常规临床实践中的初始诊断、范围评估、治疗反应评价、复发分期或随访。

临床应用与阅片要点

  • 唾液腺肿胀可触及3周时,超声检查用于确认肿瘤性病变并排除鉴别诊断。
  • 唾液腺肿瘤的影像评估以MRI为基础,采用弥散加权和动态对比增强技术。
  • 组织学证实恶性或高度可疑病变时,颈部及胸部CT用于评估肿瘤、淋巴结和转移。
  • FDG-PET目前不推荐用于常规临床实践中的初始诊断、范围评估、治疗反应评价、复发分期或随访。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To define the indications for each imaging modality in the screening, characterization, extension and follow-up of salivary gland tumors.

MATERIAL AND METHODS: The French Network of Rare Head and Neck Tumors (REFCOR) formed a steering group who drafted a narrative review of the literature published on Medline and proposed recommendations. The level of adherence to the recommendations was then assessed by a rating group, according to the formal consensus method.

RESULTS: If a swelling of a salivary gland is palpable for 3 weeks, an ultrasound scan is recommended to confirm a tumoral lesion and rule out differential diagnoses. For a salivary gland tumor, MRI is recommended with diffusion-weighted and dynamic contrast-enhanced techniques. In the case of histologically proven malignancy or a highly suspicious lesion, a CT scan of the neck and chest is recommended to assess the tumor, lymph nodes and metastases. FDG-PET is not currently recommended in routine clinical practice for initial diagnosis, assessment of extension, evaluation of response to treatment, staging of recurrence, or follow-up of salivary gland tumors.

CONCLUSION: Assessing salivary tumors is based on MRI. Extension assessment is based on neck and chest CT.

来源:Eur Ann Otorhinolaryngol Head Neck Dis,查看原文。版权归原作者所有。

引用

  1. Varoquaux A, Fakhry N, Baujat B, et al. Diagnostic imaging of salivary gland cancers: REFCOR recommendations by the formal consensus method. Eur Ann Otorhinolaryngol Head Neck Dis. 2023. PMID: 38036312. doi:10.1016/j.anorl.2023.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。